Citadel Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-654,852
| Closed | -$63.5M | – | 5408 |
|
|
2019
Q3 | $63.5M | Buy |
654,852
+22,676
| +4% | +$2.2M | 0.03% | 338 |
|
|
2019
Q2 | $64.7M | Buy |
632,176
+22,469
| +4% | +$2.3M | 0.03% | 311 |
|
|
2019
Q1 | $69.4M | Buy |
609,707
+566,607
| +1,315% | +$64.5M | 0.03% | 279 |
|
|
2018
Q4 | $1.69M | Sell |
43,100
-30,301
| -41% | -$1.19M | ﹤0.01% | 2363 |
|
|
2018
Q3 | $4M | Sell |
73,401
-30,825
| -30% | -$1.68M | ﹤0.01% | 1675 |
|
|
2018
Q2 | $8.63M | Buy |
104,226
+100,487
| +2,688% | +$8.32M | ﹤0.01% | 1090 |
|
|
2018
Q1 | $249K | Sell |
3,739
-24,445
| -87% | -$1.63M | ﹤0.01% | 3351 |
|
|
2017
Q4 | $1.45M | Buy |
28,184
+14,561
| +107% | +$749K | ﹤0.01% | 2124 |
|
|
2017
Q3 | $1.22M | Sell |
13,623
-867,281
| -98% | -$77.4M | ﹤0.01% | 2137 |
|
|
2017
Q2 | $52.6M | Buy |
880,904
+787,334
| +841% | +$47M | 0.04% | 288 |
|
|
2017
Q1 | $4.99M | Sell |
93,570
-313,342
| -77% | -$16.7M | ﹤0.01% | 1208 |
|
|
2016
Q4 | $20.3M | Buy |
+406,912
| New | +$20.3M | 0.02% | 477 |
|
|
2016
Q3 | – | Sell |
-12,728
| Closed | -$651K | – | 4308 |
|
|
2016
Q2 | $651K | Buy |
+12,728
| New | +$651K | ﹤0.01% | 2068 |
|
|
2016
Q1 | – | Sell |
-3,896
| Closed | -$177K | – | 4230 |
|
|
2015
Q4 | $177K | Sell |
3,896
-16,344
| -81% | -$743K | ﹤0.01% | 3004 |
|
|
2015
Q3 | $845K | Buy |
20,240
+15,987
| +376% | +$667K | ﹤0.01% | 2262 |
|
|
2015
Q2 | $256K | Buy |
4,253
+1,885
| +80% | +$113K | ﹤0.01% | 2923 |
|
|
2015
Q1 | $184K | Buy |
+2,368
| New | +$184K | ﹤0.01% | 3125 |
|